EQL Pharma AB (EQL.ST) stock: key figures, P/E, revenue and dividend
Health Care · Sweden · ISIN SE0005497732
Price
19.16 SEK
Market cap
565.79 m SEK
P/E (2026)
45.13
P/S (2026)
1.31
Dividend yield
0.00 %
Net margin
2.90 %
Return on equity (ROE)
4.69 %
Return on assets (ROA)
1.47 %
EQL Pharma AB financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 373.52 m SEK | 432.66 m SEK |
| Gross profit | 155.95 m SEK | 162.84 m SEK |
| Operating income | 66.35 m SEK | 47.38 m SEK |
| EBIT | 66.69 m SEK | 44.59 m SEK |
| Net income | 43.12 m SEK | 12.54 m SEK |
| Diluted EPS – continuing operations | 1.48 SEK | 0.42 SEK |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About EQL Pharma AB
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers prescription drugs, including hospital products. EQL Pharma AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
More stocks
- Mastech Digital, Inc. (MHH)
- American Clean Resources Group, Inc. (ACRG)
- Moorim P&P Co Ltd (009580.KS)
- NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC)
- Master Style PCL (MASTER.BK)
- YAS Co., Ltd. (255440.KQ)
- Sirios Resources Inc. (SOI.V)
- KSP Co. Ltd. (073010.KQ)
- Dongnam Chem (023450.KS)
- Mobiletron Electronics Co Ltd (1533.TW)
- Pansar Bhd (8419.KL)
- Pierce Group AB (PIERCE.ST)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.